International Cannabis Weekly: 289

LANDMARK UK TRIALS TO STUDY CANNABIS-BASED MEDICINE IN COMPLEX PAIN CONDITIONS

Two landmark clinical trials could pave the way for a new CBD-based medicine to be made available through the NHS for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) and endometriosis.

The trials, which are being led by top researchers at the University of Edinburgh, have received combined commitments of £1.55 million in grant funding.

In Phase II randomised control trials (RCTs), the research team will study the effects of a broad-spectrum oral tincture containing CBD isolate and additional terpenes, in treating patients with the complex inflammatory pain conditions, CIPN and endometriosis.

READ MORE »

NEW YORK’S CANNABIS CONTROL BOARD TO DOUBLE NUMBER OF LICENCES

READ MORE »

WITH AN ELECTION LOOMING, DRUGS POLICY TO BECOME A HOT BUTTON ISSUE

READ MORE »

• The association of German doctors (Vdek) wants medical cannabis to be subject to a regular evaluation process.
• A new study has found that cannabis use is common among patients with tinnitus, with most reporting it help with symptoms.
• With a general election looming, drugs policy in the UK could soon become a hot political topic.
• Czechia to curb addiction by increasing vice tax and introducing a strictly regulated cannabis market.
• NHS licensed medical cannabis prescriptions grew 45% last year, but ‘Situation as intolerable as ever’.
• The rules for industrial hemp have changed once again, updating the THC limit to 0.3%.
• The Irish government has appointed former Health Service Executive CEO to chair Citizens’ Assembly on Drugs Use.
• A study indicates CBD may be useful in reducing stress in dogs under certain circumstances.
• The VOC has provided an overview of Dutch political parties’ positions on cannabis.

NEW SPEAKER ANNOUNCEMENT – CANNABIS EUROPA LONDON

We’re thrilled to announce that The Labour Party’s Bell Ribeiro-Addy MP will be joining us as a speaker at Cannabis Europa London.

During her time in Parliament, Bell has highlighted the damaging impact of drug criminalisation and is also a patron of Labour’s Campaign for Drug Policy Reform.

SEE ALL SPEAKERS »

• The Michigan cannabis market nearly came to a total stop last week, due to a ‘clerical error’.
• Trulieve reports fourth quarter and record full year 2022 results exceeding US$1.2 billion in revenue.
• Delaware House approves cannabis legalisation bill, with action pending on complementary regulation measure.
• Legal cannabis sales in the US state of Missouri topped US$100 million in February 2023.
• Maryland lawmakers could take a key cannabis vote this week. Here’s what to watch.
• U.S. Library Of Congress compares hemp rules in countries around the world in new report.
• A Democratic senator from Kissimmee has filed a bill that could legalise recreational cannabis.
• Lawmakers in Pennsylvania want to make it easier for doctors in the state to prescribe medical cannabis to patients.

• An investor is publicly suing Canadian pharmaceutical and cannabis company Tilray Brands Inc.
• Cannara Biotech Inc. announces that it has entered into an automatic share purchase plan with Raymond James Ltd.
• A new report has revealed that Albertans almost lead the country when it comes to sales of recreational cannabis.
• The Municipality of McDougall has requested a process of approvals for cannabis production facilities.
• Blackhawk Growth’s wholly owned subsidiary TERP Wholesale signs C$80,000 product launch.
• Cannabis producers outside of Ontario are trying to make shipping to the Ontario Cannabis Store work for them.

• Cannabis extraction and therapeutic use course in Brazil to prepare participants for production.
• Argentina is moving beyond hemp flower, with 15 grain and fibre varieties now undergoing evaluation.
• Director of the Argentine Development Bank explains how and why cannabis is a bet on roots.
• Santa Cannabis has received authorisation in Brazil to cultivate cannabis.

EXPANDING INTO EUROPE IN 2023?

Showcase your products, services, and expertise to thousands of industry professionals from across Europe and beyond at Cannabis Europa 2023.

By exhibiting at Cannabis Europa London 2023, you benefit from:

• Exposure to 1500 + industry professionals
• Opportunity to connect with potential investors and partners
• Increased visibility through extensive marketing campaigns
• Access to exclusive networking events and opportunities
• A platform to showcase your latest products and services

Apply for a space at the event before they are all sold.

EXHIBIT WITH US »

• New Zealand’s largest medical cannabis cultivator, Puro, selects Elevated Signals as its seed-to-sale software provider.
• Bod Science clears stability hurdle for Aqua Phase deal, but completion of PK study delayed until 30 June 2023.
• MCIA and Epilepsy Action Australia team up to develop medicinal cannabis information portal.
• Will the Thai parliament run out of time to pass its legalisation of cannabis? The country’s lawmakers remain divided.
• Victorian Premier Dan Andrews has signalled action on medical cannabis driving laws.

• For the first time since 2021, a decrease in the number of medical cannabis patients in Israel.
• Pure Sunfarms’ varieties have arrived in Israeli pharmacies – an interview with the master grower.
• Rwanda is looking to attract at least R₣19 billion (about US$17.5 million) investment in the production of cannabis.
• Morocco has opened the country’s first laboratory for medical and industrial use of cannabis.
• Morocco’s USFP delegation in Latin America to discuss the legalisation of cannabis.
• The Israeli medical cannabis market no longer appears to be the haven it once was.